If Novo were to lose such a case based on a judgment of patent invalidity, it could potentially lose its exclusive rights to semaglutide, meaning that others (not just Hims) would be free to use, make, and sell it without infringing
Peptides like this one are fragile molecules, and an injectable, subcutaneous form is generally the most predictable way to deliver a known, stable amount into the body
The primary distinction lies in their fundamental composition
doi: 10.1038/s41467-020-14309-w Ast J, Novak AN, Podewin T, Fine NHF, Jones B, Tomas A, Birke R, Romann K, Mathes B, Eichhorst J, Lehmann M, Linnemann AK, Hodson DJ, Broichhagen J
suis infection in pigs
They also have a higher density of estrogen receptors, which affects fat distribution, and experience pronounced age-related collagen decline, reducing skin firmness